Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial

被引:2
|
作者
Blom, Kerstin [1 ,2 ]
Forsell, Erik [1 ,2 ]
Hellberg, Monica [2 ]
Svanborg, Cecilia [1 ,2 ]
Jernelov, Susanna [1 ,2 ,3 ]
Kaldo, Viktor [1 ,2 ,4 ]
机构
[1] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden
[2] Stockholm Hlth Care Serv, Stockholm, Sweden
[3] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden
[4] Linnaeus Univ, Fac Hlth & Life Sci, Dept Psychol, Vaxjo, Sweden
关键词
Insomnia; Depression; Comorbidity; Psychological treatment; Randomized controlled trial; COGNITIVE-BEHAVIORAL THERAPY; SLEEP RESTRICTION THERAPY; SELF-HELP; DSM-IV; MAJOR DEPRESSION; SOCIAL ANXIETY; FOLLOW-UP; CBT-I; METAANALYSIS; PHARMACOTHERAPY;
D O I
10.1159/000536063
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Insomnia and depression are highly prevalent disorders and commonly occur together. Cognitive behavioral therapy for insomnia, CBT-I, has been shown to be effective in treating insomnia and also comorbid depression. However, it is unclear whether effects of CBT-I on depression are specific or nonspecific. Also, depressive symptoms often remain too high after CBT-I, indicating a need for improved treatments. The objective was to determine whether combining CBT-I with CBT for depression, without increasing treatment length, reduces both insomnia and depression more than CBT for depression with a placebo insomnia intervention. Methods: A 12-week double-blind randomized controlled trial with a 6-month follow-up in a psychiatric setting using therapist-guided internet-delivered treatments was conducted. Patients (N = 126) were diagnosed with insomnia disorder and major depression by physicians. Primary outcome measures were as follows: self-rating scales Insomnia Severity Index (ISI) and Montgomery-angstrom sberg Depression Rating Scale (MADRS-S). Results: The combined treatment showed specific effects on insomnia severity over the control treatment (p = 0.007) but was not more effective in reducing depression severity. Within-group effects (Cohen's d) at post and at 6 months were as follows: ISI 1.40 and 1.42 (combined treatment), 0.95 and 1.00 (control); MADRS-S 0.97 and 1.12 (combined), 0.88 and 0.89 (control). Conclusions: CBT-I shows large specific effects on insomnia severity and is superior to control in this regard. Both treatments had similar effects on depression severity, i.e., combining CBT-I with CBT for depression did not enhance outcomes on depression compared to control. We suggest CBT-I should always be offered to patients with insomnia and depression comorbidity, possibly as the first-hand choice. Combining it with a psychological treatment for depression could be too burdening and may not be beneficial.
引用
收藏
页码:100 / 113
页数:14
相关论文
共 50 条
  • [1] DEXAMETHASONE FOR THE TREATMENT OF DEPRESSION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    ARANA, GW
    SANTOS, AB
    LARAIA, MT
    MCLEODBRYANT, S
    BEALE, MD
    RAMES, LJ
    ROBERTS, JM
    DIAS, JK
    MOLLOY, M
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (02): : 265 - 267
  • [2] A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression
    Wagner, KD
    Jonas, J
    Findling, RL
    Ventura, D
    Saikali, K
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (03): : 280 - 288
  • [3] The Impact of Eszopiclone Insomnia Treatment on Cognition in Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial
    Tek, Cenk
    Palmese, Laura B.
    Krystal, Andrew D.
    DeGeorge, Pamela C.
    Reutenauer, Erin L.
    Guloksuz, Sinan
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 341S - 342S
  • [4] Efficacy of individualized homeopathic treatment of insomnia: Double-blind, randomized, placebo-controlled clinical trial
    Michael, James
    Singh, Subhas
    Sadhukhan, Satarupa
    Nath, Arunava
    Kundu, Nivedita
    Magotra, Nitin
    Dutta, Susmit
    Parewa, Maneet
    Koley, Munmun
    Saha, Subhranil
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 43 : 53 - 59
  • [5] Fluoxetine for depression in diabetes - A randomized double-blind placebo-controlled trial
    Lustman, PJ
    Freedland, KE
    Griffith, LS
    Clouse, RE
    DIABETES CARE, 2000, 23 (05) : 618 - 623
  • [6] A Randomized, Double-Blind, Placebo-Controlled Trial of Pregnenolone for Bipolar Depression
    E Sherwood Brown
    John Park
    Christine E Marx
    Linda S Hynan
    Claire Gardner
    Domingo Davila
    Alyson Nakamura
    Prabha Sunderajan
    Alexander Lo
    Traci Holmes
    Neuropsychopharmacology, 2014, 39 : 2867 - 2873
  • [7] Escitalopram in the Treatment of Adolescent Depression: A Randomized, Double-Blind, Placebo-Controlled Extension Trial
    Findling, Robert L.
    Robb, Adelaide
    Bose, Anjana
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (07) : 468 - 480
  • [8] A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression
    Liisa Hantsoo
    Deborah Ward-O’Brien
    Kathryn A. Czarkowski
    Ralitza Gueorguieva
    Lawrence H. Price
    C. Neill Epperson
    Psychopharmacology, 2014, 231 : 939 - 948
  • [9] A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression
    Hantsoo, Liisa
    Ward-O'Brien, Deborah
    Czarkowski, Kathryn A.
    Gueorguieva, Ralitza
    Price, Lawrence H.
    Epperson, C. Neill
    PSYCHOPHARMACOLOGY, 2014, 231 (05) : 939 - 948
  • [10] A Randomized, Double-Blind, Placebo-Controlled Trial of Pregnenolone for Bipolar Depression
    Brown, E. Sherwood
    Park, John
    Marx, Christine E.
    Hynan, Linda S.
    Gardner, Claire
    Davila, Domingo
    Nakamura, Alyson
    Sunderajan, Prabha
    Lo, Alexander
    Holmes, Traci
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (12) : 2867 - 2873